Zenvista Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 1.00 M
as on 14-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 14.00%
(FY 2020)
- Profit 154.18%
(FY 2020)
- Ebitda 217.33%
(FY 2020)
- Net Worth 88.53%
(FY 2020)
- Total Assets 56.71%
(FY 2020)
About Zenvista Meditech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chanchal Singh and Tarandeep Kaur serve as directors at the Company.
- CIN/LLPIN
U74999UR2013PTC000917
- Company No.
000917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zenvista Meditech Private Limited offer?
Zenvista Meditech Private Limited offers a wide range of products and services, including Cosmetic Bottle, Plastic Hair Oil Bottle, Plastic Bottles, PET Bottles, Lotion Bottle, Glass Bottles, Glass Dropper Bottle, Cosmetic Container, Cream Jar, Amber Glass Bottle.
Who are the key members and board of directors at Zenvista Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chanchal Singh  | Director | 31-Oct-2013 | Current |
| Tarandeep Kaur | Director | 31-Oct-2013 | Current |
Financial Performance of Zenvista Meditech.
Zenvista Meditech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14% increase. The company also saw a substantial improvement in profitability, with a 154.18% increase in profit. The company's net worth Soared by an impressive increase of 88.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenvista Meditech?
In 2020, Zenvista Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenvista Meditech?
Unlock and access historical data on people associated with Zenvista Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenvista Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenvista Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
